Clinical trial
Point of Care Diagnostic to Identify the Causative Agent of the Plague in Blood Samples
NCT04688996 is registered in ClinicalTrials.gov with Brimrose Technology Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Point of Care Diagnostic to Identify the Causative Agent of the Plague in Blood Samples
- Lead sponsor
- Brimrose Technology Corporation
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 19, 2020
- Completion date
- January 31, 2023
- Enrollment
- 500 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
bubo; yersinia pestis, bubonic; plague, skin, plague, plague, bubonic, plague, pneumonic, pneumonic plague, yersinia pestis infection, yersinia pestis plague, yersinia pestis; bubo, yersinia pestis; pneumonia, yersinia sepsis